Enhanced school-based surveillance of acute adverse events following immunisation with human papillomavirus vaccine in males and females, 2013
Australia was the first country to introduce a government-funded National Human Papillomavirus (HPV) Vaccination Program for females. From 2007 to 2012, the TGA captured national adverse event reports via routine passive surveillance. In 2013, the National Immunisation Program (NIP) schedule was extended to include males (12 to 13 years as standard and a two year Read More …